Lymph node dissection plays expanding role in urology

Less than 20 years ago, lymphadenectomy and lymph node dissection were primarily used as staging procedures. Today, studies have shown that the procedures can increase the survival rates in patients with a host of urologic cancers. In this exclusive interview, Urs Studer, MD, professor and chairman of the department of urology, University of Bern, Switzerland, discusses the expanding role of lymph node dissection in bladder, prostate, and kidney cancer. The interview was conducted by UT Editorial Consultant Robert C. Flanigan, MD, professor and chairman of the department of urology at Loyola University Medical Center, Maywood, IL.